G. E. Friedlaender, C. R. Perry, J. D. Cole, S. D. Cook, G. Cierny, G. F. Muschler, et al., “Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions,” The Journal of Bone & Joint Surgery, Vol. 83-A, Suppl. 1(Pt 2): 2001, pp. S151-S158.
 S. Govender, C. Csimma, H. K. Genant, A. Valentin-Opran, Y. Amit, R. Arbel, et al., “Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients,” The Journal of Bone & Joint Surgery, Vol. 84-A, No. 12, 2002, pp. 2123-2134.
 T. Sibai and E. F. Morgan, T. A. Einhorn, “Anabolic Agents and Bone Quality,” Clinical Orthopaedics and Related Research, Vol. 469, No. 8, 2011, pp. 2215-2224.
 A. Linde, P. Alberius, C. Dahlin, K. Bjurstam and Y. Sundin, “Osteopromotion: A Soft-Tissue Exclusion Principle Using a Membrane for Bone Healing and Bone Neogenesis,” Journal of Periodontology, Vol. 64, Suppl. 11, 1993, pp. 1116-1128.
 H. C. Brownlow and A. H. Simpson, “Metabolic Activity of a New Atrophic Nonunion Model in Rabbits,” Journal of Orthopaedic Research, Vol. 18, No. 3, 2000, pp. 438-442.
 A. A. Reed, C. J. Joyner, H. C. Brownlow and A. H. Simpson, “Human Atrophic Fracture Non-Unions Are Not Avascular,” Journal of Orthopaedic Research, Vol. 20, No. 3, 2002, pp. 593-599.
 H. Eckardt, K. S. Christensen, M. Lind, E. S. Hansen, D. W. Hall and I Hvid, “Recombinant Human Bone Morphogenetic Protein 2 Enhances Bone Healing in an Experimental Model of Fractures at Risk of Non-Union,” Injury, Vol. 36, No. 4, 2005, pp. 489-494.
 M. L. Radomsky, A. Y. Thompson, R. C. Spiro and J. W. Poser, “Potential Role of Fibroblast Growth Factor in Enhancement of Fracture Healing,” Clinical Orthopaedics and Related Research, Suppl. 355, 1998, pp. S283-S293.
 H. E. Stender, S. Z. He, V. E. Hjortdal, D. Kjolseth and K. Soballe, “Distribution of Blood Flow in Normal and Arthritic Joints. Role of Arteriovenous Shunting Studied in Growing Dogs,” American Journal of Physiology—Heart and Circulatory Physiology, Vol.262(1 Part 2), 1992, pp. H38-H46.
 P. Ruegsegger, B. Koller and R. Muller, “A Microtomographic System for the Nondestructive Evaluation of Bone Architecture,” Calcified Tissue International, Vol. 58, No. 1, 1996, pp. 24-29.
 M. S. Tonetti, P. Cortellini, J. E. Suvan, P. Adriaens, C. Baldi, D. Dubravec, et al., “Generalizability of the Added Benefits of Guided Tissue Regeneration in the Treatment of Deep Intrabony Defects. Evaluation in a Multi-Center Randomized Controlled Clinical Trial,” Journal of Periodontology, Vol. 69, No. 11, 1998, pp. 1183-1192.
 R. Dimitriou, G. I. Mataliotakis, G. M. Calori and P. V. Giannoudis, “The Role of Barrier Membranes for Guided Bone Regeneration and Restoration of Large Bone Defects: Current Experimental and Clinical Evidence,” BMC Medicine, Vol. 10, 2012, p. 81.
 G. Zellin and A. Linde, “Treatment of Segmental Defects in Long Bones Using Osteopromotive Membranes and Recombinant Human Bone Morphogenetic Protein-2. An Experimental Study in Rabbits,” Journal of Plastic Surgery and Hand Surgery, Vol. 31, No. 2, 1997, pp. 97-104.
 A. Linde and E. Hedner, “Recombinant Bone Morphogenetic Protein-2 Enhances Bone Healing, Guided by Osteopromotive e-PTFE Membranes: An Experimental Study in Rats,” Calcified Tissue International, Vol. 56, No. 6, 1995, pp. 549-553.